Geneva, Aug. 31 -- International Clinical Trials Registry received information related to the study (NCT07779265) titled 'Effects of Probiotic Supplementation on Gut Health, Immune Response, and Well-Being' on Aug. 19.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Double (Participant, Investigator).
Primary Sponsor: Orthomol Pharmazeutische Vertiebs GmbH
Condition:
Gut Microbiome
Immune Responses
Well-being
Intervention:
Dietary Supplement: Probiotic capsules
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: August 13, 2026
Target Sample Size: 50
Countries of Recruitment:
Germany
To know more, visit https:/...